Screening mammography & breast cancer mortality: Meta-analysis of quasi-experimental studies

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Irvin, Veronica L ^a   Kaplan, Robert M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAMMOGRAPHY; META ANALYSIS; MIDDLE AGED; QUASI EXPERIMENTAL STUDY; RISK REDUCTION; SYSTEMATIC REVIEW; BREAST NEOPLASMS; COHORT ANALYSIS; CONFIDENCE INTERVAL; EARLY DIAGNOSIS; GEOGRAPHY; MORTALITY; PUBLISHING; RISK FACTOR;

BREAST NEOPLASMS; COHORT STUDIES; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; FEMALE; GEOGRAPHY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PUBLICATION BIAS; RISK FACTORS;

EID: 84902322666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098105     Document Type: Article

References (58)

1. Anttila A, Koskela J, Hakama M (2002) Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9: 153-8. (Pubitemid 36135340)
2. Duffy S, Tabar L, Smith RA (2002) The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. J Surg Oncol 81: 159-62; discussion 62-6.
3. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, et al. (2010) Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen17: 25-30.
4. Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, et al. (2002) Are breast cancer screening programmes increasing rates of mastectomy? Observational study. BMJ 325: 418. (Pubitemid 34969791)
5. Woloshin S, Schwartz LM (2012) How a charity oversells mammography. BMJ 345: e5132.
6. Biller-Andormo N, Juni P (2014) Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. Epub ahead of print. DOI: 10.1056/NEJMp1401875.
7. Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 19: CD001877.
8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, et al. (2009) Screening for breast cancer: Systematic evidence review update for the U.S. Preventive Services Task Force. Ann Intern Med 151: 727-737, W237-W242.
9. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, et al. (2013) The benefits and harms of breast cancer screening: an independent review. Br J Cancer 108(11): 2205-2240.
10. Duffy SW, Yen Ming-Fang A, Chen TH, Chen SL, Chui SY, et al. (2012) Long-term benefits of breast screening. Breast Cancer Manage 1: 31-38.
11. Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137(5): 347-360. (Pubitemid 34977137)
12. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380(9855): 1778-1786.
13. Leung GM, Lam TH, Thach TQ, Hedley AJ (2002) Will screening mammography in the East do more harm than good? Am J Public Health 92: 1841-1846. (Pubitemid 35231149)
14. Black WC, Haggstrom DA, Welch HG (2002) All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 94(3): 167-173. (Pubitemid 34162750)
15. Tabar L, Duffy SW, Yen M-F, Warwick J, Vitak B, et al. (2002) All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen. 9: 159-162. (Pubitemid 36135341)
16. Rothwell PM (2005) External validity of randomized controlled trials: "to whom do the results of this trial apply?" Lancet 365(9453): 82-93.
17. Sanson-Fisher RW, Bonevski B, Green LW, D'Este C (2007) Limitations of the randomized controlled trial evaluating population-based health interventions. Am J Prev Med 33(2): 155-161. (Pubitemid 47126234)
18. Coldman A, Phillips N (2011) Population studies of the effectiveness of mammographic screening. Prev Med 53: 115-117.
19. Gabe R, Duffy SW (2005) Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 16: ii53-ii62.
20. Harris R, Yeatts J, Kinsinger L (2011) Breast cancer screening for women ages 50-69 years a systematic review. Prev Med 53: 108-114.
21. Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45: 1916-1923.
22. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, et al. (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19: 14-25.
23. Njor S, Nystrom L, Moss S, Paci E, Broeders M, et al. (2012) Breast cancer mortality in mammographic screening in Europe: a review of incidence-based morality studies. J Med Screen 19: 33-41.
24. Hakama M, Pukkala E, Heikkilä M, Kallio M (1997) Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 314 (7084): 864-867. (Pubitemid 27182019)
25. Hakama M, Pukkala E, Soderman B, Day N (1999) Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen 6: 209-216. (Pubitemid 30084247)
26. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, et al. (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95: 458-469. (Pubitemid 34810170)
27. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, et al. (2003) Mammography service screening and mortality in breast cancer patients: a 20-year follow-up before and after introduction of screening. Lancet 361: 1405-1410. (Pubitemid 36515039)
28. Swedish Organised Service Screening Evaluation Group (SOSSEG) (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15: 45-51.
29. Jorgensen KJ, Zahl PH, Gotzsche PC (2010) Breast cancer screening mortality in organized mammography screening in Denmark: comparative study. BMJ 340: c1241.
30. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, et al. (2005) Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 330: 220-224.
31. Van Dijck JA, Verbeek AL, Beex LV, Hendriks JH, Holland R, et al. (1997) Breast cancer mortality in a non-randomized trial on mammographic screening in women over age 65. Int J Cancer 70: 164-168. (Pubitemid 27107412)
32. Broeders MJ, Peer PG, Straatman H, Beex LV, Hendriks JH, et al. (2001) Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997. Int J Cancer 92: 303-308. (Pubitemid 32225385)
33. Olsen AH, Lynge E, Njor SH, Kumle M, Waaseth M, et al. (2013) Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer 132: 208-214.
34. Kalager M, Zelen M, Langmark F, Adami H-O (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363: 1203-1210.
35. Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326: 219. (Pubitemid 36143396)
36. Hakama M, Pukkala E, Kallio M, Godenhjelm K, Svinhufvud U (1995) Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland. Int J Cancer 63: 55-57.
37. Ascunce EN, Moreno-Iribas C, Urtiaga AB, Ardanaz E, Ederra Sanz M, et al. (2007) changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 14: 14-20. (Pubitemid 46440360)
38. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, et al. (2003) Initiation of population-based mammography screening in Dutch municipalities and effect of breast-cancer mortality: a systematic review. Lancet 361: 1411-1417. (Pubitemid 36515040)
39. Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, et al. (2011) Effectiveness of population-based service screening with mammography for women ages 40-49 years. Cancer 117: 714-722.
40. Jonsson H, Bordas P, Wallin H, Nystrom L, Lenner P (2007) Services screening with mammography in Northern Sweden: effects of breast cancer mortality - an update. J Med Screen 14: 87-93. (Pubitemid 47067763)
41. No authors (1999) 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 353: 1909-1914.
42. Peer PGM, Were JM, Mravunac M, Hendriks JH, Holland R, et al. (1995) Effect on breast cancer mortality of biennial mammographic screening of women under age 50. Int J Cancer 60: 808-811.
43. Jonsson H, Tornberg S, Nystrom L, Lenner P (2000) Service screening with mammography in Sweden. Acta Oncol 39: 617-623.
44. Jonsson H, Nystrom L, Tornberg S, Lenner P (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8: 152-160. (Pubitemid 32936633)
45. Jonsson H, Nystrom L, Tornberg S, Lundgren B, Lenner P (2003) Service screening with mammography: Long-term effects on breast cancer mortality in the county of Gavleborg, Sweden. Breast 12: 183-193. (Pubitemid 36675320)
46. Jonsson H, Tornberg S, Nystrom L, Lenner P (2003) Service screening with mammography of women aged 70-74 years in Sweden effects on breast cancer mortality. Cancer Detect Prev 27: 360-369. (Pubitemid 37374932)
47. Parvinen I, Helenius H, Pylkkanen, Anttila A, Immonen-Raiha P, et al. (2006) Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 13: 34-40. (Pubitemid 43843763)
48. Campbell DT, Stanley JC (1963) Experimental and quasi-experimental designs for research. Chicago, IL: Rand McNally.
49. Grembowski D (2001) The Practice of Health Program Evaluation. Thousand Oaks, CA: Sage Publications, 89-91.
50. Miller AB, Wall C, Baines CJ, Sun P, To T, et al. (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ 348: g366.
51. Lynge E, Braaten T, Njor SH, Olsen AH, Kumle M, et al. (2011) Mammography activity in Norway 1983-2008. Acta Oncol 50: 1062-1067.
52. Toriola AT, Colditz GA (2013) Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat 138: 665-673.
53. Sun E, Jena AB, Lakdawalle D, Reyes C, Philipson TJ, et al. (2010) The contributions of improved therapy and earlier detection to cancer survival gains, 1988-2000. Forum Health Econ Policy. 13(2) Article 1. Available: http://www.degruyter.com/view/j/fhep.2010.13.2/fhep.2010.13.2.1195/fhep.2010.13. 2.1195.xml. Accessed 2014 May 8.
54. Sarkeala T, Heinavaara S, Anttila A (2008) Breast cancer mortality with varying invitational policies in organized mammography. Br J Cancer 98: 641-645. (Pubitemid 351214531)
55. Zakharova N, Duffy SW, Mackay J, Kotlyarov E (2011) The introduction of a breast cancer screening programme in a region with a population at medium risk for developing breast cancer: Khanty-Mansiysky autonomous Okrug-Ugra (Russian Federation). Ecancermedicalscience 5: 195.
56. Cooper GS, Yuan Z, Bowlin J, Dennis LK, Kelly R, et al. (1998) An ecological study of the effectiveness of mammography in reducing breast cancer mortality. Am J Public Health 8: 281-284. (Pubitemid 28134092)
57. Anderson WF, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 99: 333-340. (Pubitemid 44337926)
58. Olsen AH, Njor SH, Vejborg I, Scwartz W, Dalgaard P, et al. (2005) A model for determining the effect of mammography service screening. Acta Oncol 44: 120-128. (Pubitemid 40523369)